Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elemene plus S-1 vs S-1 alone after surgery for advanced gastric cancer
ChiCTR2200062109Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2022
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Elemene and tegafur in gastric cancer (GC) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Cellular immunologic parameters. Started Aug 2022; status: recruiting.
02
Drugs
Elemenetegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR2200062109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062109.